Rabbit Polyclonal Gpihbp1 antibody. Suitable for WB, IHC-P and reacts with Rat, Mouse, Human samples. Cited in 3 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human GPIHBP1.
View Alternative Names
HBP1, GPIHBP1, Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1, GPI-HBP1, GPI-anchored HDL-binding protein 1, High density lipoprotein-binding protein 1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Gpihbp1 antibody (AB224728)
Paraffin-embedded human skin tissue stained for Gpihbp1 with ab224728 at 1/20 dilution in immunohistochemical analysis.
- WB
Supplier Data
Western blot - Anti-Gpihbp1 antibody (AB224728)
All lanes:
Western blot - Anti-Gpihbp1 antibody (ab224728) at 1/500 dilution
Lane 1:
Rat liver tissue lysate
Lane 2:
Mouse heart tissue lysate
Lane 3:
Mouse lung tissue lysate
Lane 4:
Mouse kidney tissue lysate
Secondary
All lanes:
Goat polyclonal to rabbit IgG at 1/50000 dilution
Predicted band size: 20 kDa
Observed band size: 20 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The presence of GPIHBP1 is essential for the proper functioning of the lipolysis process enabling the breakdown of triglycerides into free fatty acids and glycerol. It forms a stable complex with LPL that is necessary for LPL's movement from interstitial spaces to the luminal surface of capillaries. Without this function the processing of lipid particles in the bloodstream would be disrupted affecting the availability of free fatty acids for uptake by tissues.
Pathways
GPIHBP1 participates significantly in the lipid metabolism pathway specifically concerning the regulation of plasma triglyceride levels. This pathway includes key interactions with other proteins such as chylomicrons which it assists in metabolizing and apolipoprotein C-II a cofactor required for LPL activity. GPIHBP1 ensures that LPL is correctly localized to execute its function in hydrolyzing triglycerides in these pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Translational lung cancer research 14:491-512 PubMed40114952
2025
Applications
Unspecified application
Species
Unspecified reactive species
Translational cancer research 13:2691-2703 PubMed38988918
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 13: PubMed33669398
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com